See more : Coventry Group Ltd (CVTYF) Income Statement Analysis – Financial Results
Complete financial analysis of The Hempshire Group, Inc. (HMPSF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Hempshire Group, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- santec Holdings Corporation (6777.T) Income Statement Analysis – Financial Results
- Salcef Group S.p.A. (SCF.MI) Income Statement Analysis – Financial Results
- COFCO Engineering & Technology Co., Ltd. (301058.SZ) Income Statement Analysis – Financial Results
- Vine Hill Capital Investment Corp. (VCIC) Income Statement Analysis – Financial Results
- Astena Holdings Co., Ltd. (8095.T) Income Statement Analysis – Financial Results
The Hempshire Group, Inc. (HMPSF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://mountainsmokes.com
About The Hempshire Group, Inc.
Hempshire Group, Inc. engages in the sourcing, manufacturing, branding, and processing of pharmaceutical grade hemp and CBD products. Hempshire Group, Inc. was founded in 2019 and is based in Palm Springs, California.
| Metric | 2022 | 2021 | 2020 |
|---|---|---|---|
| Revenue | 89.07K | 286.35K | 297.75K |
| Cost of Revenue | 63.45K | 151.82K | 168.92K |
| Gross Profit | 25.62K | 134.54K | 128.83K |
| Gross Profit Ratio | 28.77% | 46.98% | 43.27% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.87M | 1.49M | 178.22K |
| Selling & Marketing | 414.83K | 362.48K | 106.60K |
| SG&A | 2.28M | 1.86M | 412.21K |
| Other Expenses | 287.38K | 0.00 | 0.00 |
| Operating Expenses | 2.57M | 1.83M | 407.44K |
| Cost & Expenses | 2.63M | 1.98M | 576.35K |
| Interest Income | 15.30K | 1.71K | 17.50K |
| Interest Expense | 246.37K | 76.38K | 0.00 |
| Depreciation & Amortization | 40.66K | 18.03K | 5.23K |
| EBITDA | -6.22M | -1.93M | -283.38K |
| EBITDA Ratio | -6,978.65% | -585.84% | -95.17% |
| Operating Income | -2.54M | -1.74M | -288.61K |
| Operating Income Ratio | -2,854.97% | -607.02% | -96.93% |
| Total Other Income/Expenses | -3.96M | -425.19K | -7.50K |
| Income Before Tax | -6.50M | -2.16M | -296.11K |
| Income Before Tax Ratio | -7,300.91% | -755.50% | -99.45% |
| Income Tax Expense | 0.00 | 76.38K | 0.00 |
| Net Income | -6.50M | -2.16M | -296.11K |
| Net Income Ratio | -7,300.91% | -755.50% | -99.45% |
| EPS | -0.10 | -0.03 | -0.03 |
| EPS Diluted | -0.10 | -0.03 | -0.03 |
| Weighted Avg Shares Out | 66.34M | 79.57M | 8.64M |
| Weighted Avg Shares Out (Dil) | 66.34M | 79.57M | 8.64M |
Source: https://incomestatements.info
Category: Stock Reports